ArticleJournal of cutaneous medicine and surgery
Epidemiology and Comorbidities of Psychodermatologic Conditions.
Article in Journal of cutaneous medicine and surgery. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Association of BMI, BMR, BSA, and body weight with psoriasis severity and treatment response: evidence from a real-world cohort.Journal of translational medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
introductionPsychodermatologic conditions include primary psychodermatologic disorders (PPDs), psychological conditions manifesting with dermatologic symptoms, and psychophysiological disorders, dermatologic conditions influenced by psychological stress. Despite their clinical significance and considerable impact on quality of life, the comprehensive epidemiology and neuropsychiatric comorbidity profiles of these disorders remain limited.
objectivesTo evaluate the prevalence and comorbidity profiles of psychodermatologic conditions in a diverse, population-based cohort.
methodsA nested, case-control study was conducted using data from the All of us research program. From 287,011 eligible participants, 984 patients with PPDs (trichotillomania, skin picking disorder, dermatitis artefacta, body dysmorphic disorder, delusions of parasitosis) and 40,535 patients with psychophysiological disorders (psoriasis, atopic dermatitis, acne vulgaris, hidradenitis suppurativa, vulvodynia) were identified using International Classification of Diseases, 10th Revision, Clinical Modification codes. Each patient was paired with 4 controls based on age, sex, and race/ethnicity using nearest-neighbor propensity score matching. Multivariable logistic regression calculated adjusted odds ratios (aOR) and 95% confidence intervals to evaluate associations with various neuropsychiatric comorbidities.
resultsPPDs showed low point prevalences (range: ≤0.01-0.17%) but demonstrated markedly higher odds of neuropsychiatric comorbidities, including depressive disorders (range: aOR, 5.72-13.94), anxiety disorders (range: aOR, 5.96-8.40), and personality disorders (range: aOR, 8.67-13.56 Psychophysiological disorders had higher prevalence rates (range: 0.14%-5.72%) but showed more moderate associations, including depressive disorders (range: aOR, 2.24-3.13), neurodevelopmental disorders (range: aOR, 1.20-2.36), and sleep-wake disorders (range: aOR, 2.25-3.95).
conclusionsFindings reveal distinct but overlapping comorbidity profiles between PPDs and psychophysiological disorders, emphasizing the need for tailored interventions that address the psychosocial and biological complexities of these conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.